The Circulating Cell-Free Tumor DNA Market is experiencing a remarkable surge worldwide, driven by its pivotal role in non-invasive cancer diagnostics, treatment monitoring, and personalized medicine. This article delves into the factors fueling the market's growth, its size, segments, and forecasts for the period between 2023 and 2027.
Market Dynamics:
Circulating Cell-Free Tumor DNA refers to the fragments of DNA released by cancer cells ... Read more
